Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Management Over Routine Intervention: Evidence Against Early Ibuprofen for PDA From Combined Retrospective and Meta-Analytic Data

NCT07533721 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT07533721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07533721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Management Over Routine Intervention: Evidence Against Early Ibuprofen for PDA From Combined Retrospective and Meta-Analytic Data
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
June 30, 2025
Enrollment
541 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infant, premature, patent ductus arteriosus